FDA Class II Recall Watch: 16–22 August 2026
Eight selected FDA Class II recall events for 16–22 August 2026 highlight neonatal breathing-circuit failures, erroneous diagnostic results, software-driven measurement and analyzer risks, an implant machining defect, endotoxin-related surgical-kit actions, a CT bolus-tracking issue, and high-volume urostomy pouch leakage. The issue emphasizes clinical follow-up, inventory control, result review, software correction, and component-level quality management.